BIOMAT Database Logo BIOMAT Database Logo

In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide. 1978

G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky

1-(2,6-Dimethylphenyl)-3-methyl-amidinourea hydrochloride (WHR-1142A, lidamidine hydrochloride) was shown to have potent antimotility, antidiarrheal and intestinal antisecretory activity in mice, rats and dogs. Antimotility activity was demonstrated in charcoal intestinal motility, gastric emptying and gastric and intestinal intraluminal pressure studies. Antidiarrheal activity was evaluated in castor oil-, prostaglandin E2-, carbachol-, and serotonin-induced diarrhea. Intestinal secretion induced by cholera toxin was inhibited by WHR-1142A. In general, WHR-1142A was more potent than diphenoxylate and loperamide although species differences were noted. The ED50 for inhibition of castor oil-induced diarrhea was 1.8 mg/kg p.o. and the duration of action at 16 mg/kg p.o. was at least 6 h. Unlike diphenoxylate, WHR-1142A showed no tolerance.

UI MeSH Term Description Entries
D007540 Isonipecotic Acids Acids, Isonipecotic
D008139 Loperamide One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. Imodium,Loperamide Hydrochloride,Loperamide Monohydrochloride,R-18553,Hydrochloride, Loperamide,Monohydrochloride, Loperamide,R 18553,R18553
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D002217 Carbachol A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. Carbamylcholine,Carbacholine,Carbamann,Carbamoylcholine,Carbastat,Carbocholine,Carboptic,Doryl,Isopto Carbachol,Jestryl,Miostat,Carbachol, Isopto
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004157 Diphenoxylate A MEPERIDINE congener used as an antidiarrheal, usually in combination with ATROPINE. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. Diphenoxylate Hydrochloride,Diphenoxylate Monohydrochloride,Hydrochloride, Diphenoxylate,Monohydrochloride, Diphenoxylate

Related Publications

G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Toxicity studies on lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
January 1978, Arzneimittel-Forschung,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Analytical-physical profile of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
January 1978, Arzneimittel-Forschung,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
January 1978, Arzneimittel-Forschung,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
January 1978, Arzneimittel-Forschung,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
[Double-blind evaluation of the effectiveness of lidamidine hydrochloride (WHR-1142A) vs loperamide vs. placebo in the treatment of acute diarrhea].
January 1981, Salud publica de Mexico,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
August 1988, The Journal of pharmacology and experimental therapeutics,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Absence of mutagenic activity of WHR-1142A, lidamidine hydrochloride, in 4 short-term tests for mutagenic/carcinogenic potential.
March 1983, Mutation research,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
EVALUATION OF AN ANTIDIARRHEAL AGENT. DIPHENOXYLATE HYDROCHLORIDE.
January 1964, JAMA,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine.
October 1974, Arzneimittel-Forschung,
G N Mir, and R L Alioto, and J W Sperow, and J R Eash, and J B Krebs, and J Yelnosky
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 2: in vivo parenteral pharmacology and acute toxicity in mice. Comparison with morphine, codeine and diphenoxylate.
October 1974, Arzneimittel-Forschung,
Copied contents to your clipboard!